Inhibiting platelet-derived growth factor β reduces Ewing's sarcoma growth and metastasis in a novel orthotopic human xenograft model

In Vivo

Volumn 23, Issue 6, 2009, Pages 903-909

  Wang, Yong Xin ^a   Mandal, Deendayal ^b   Wang, Suizhau ^a   Hughes, Dennis ^a   Pollock, Raphael E ^a   Lev, Dina ^a   Kleinerman, Eugenie ^a   Hayes Jordan, Andrea ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Ewing's sarcoma; Orthotopic; PDGFR

Indexed keywords

PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; EWING SARCOMA; FEMALE; HUMAN; HUMAN CELL; LUNG METASTASIS; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; OVERALL SURVIVAL; PATHOGENESIS; THORAX WALL; TUMOR XENOGRAFT;

EID: 75149180461     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Gurney JG, Severson RK, Davis S and Robison LL: Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 75: 2186-2195, 1995.
2. Horowitz ME, Kinsella TJ, Wexler LH, Belasco J, Triche T, Tsokos M, Steinberg SM, McClure L, Longo DL, Steis RG et al: Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 11: 1911-1918, 1993.
3. Wexler LH, DeLaney TF, Tsokos M, Avila N, Steinberg SM, Weaver-McClure L, Jacobson J, Jarosinski P, Hijazi YM, Balis FM and Horowitz ME: Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer 78: 901-911,1996.
4. Bolontrade MF, Zhou RR and Kleinerman ES: Vasculogenesis plays a role in the growth of Ewing's sarcoma in vivo. Clin Cancer Res 8: 3622-3627, 2002.
5. Guan H, Zhou Z, Wang H, Jia SF, Liu W and Kleinerman ES: A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model. Clin Cancer Res 11: 2662-2669, 2005.
6. Vormoor J, Baersch G, Decker S, Hotfilder M, Schafer KL, Pelken L, Rube C, Van Valen F, Jürgens H and DockhornDworniczak B: Establishment of an in vivo model for pediatric Ewing tumors by transplantation into NOD/scid mice. Pediatr Res 49: 332-341, 2001.
7. Uren A, Merchant MS, Sun CJ, Vitolo MI, Sun Y, Tsokos M, Illei PB, Ladanyi M, Passaniti A, Mackall C and Toretsky JA: Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells. Oncogene 22: 232A-2342, 2003.
8. Jia SF, Zhou RR and Kleinerman ES: Nude mouse lung metastases models of osteosarcoma and Ewing's sarcoma for evaluating new therapeutic strategies. Methods MoI Med 74: 495-505,2003.
9. + stem cells into the expanding tumor vasculature. Int J Cancer 119: 839-846, 2006.
10. Tatsuguchi A, Matsui K, Shinji Y, Gudis K, Tsukui T, Kishida T, Fukuda Y, Sugisaki Y, Tokunaga A, Tajiri T and Sakamoto C: Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum Pathol 35: 488-495, 2004.
11. Zhang P, Yang Y, Zweidler-McKay PA and Hughes DP: Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res 14: 2962-2969, 2008.
12. Hu-Lieskovan S, Heidel JD, Bartlett DW, Davis ME and Triche TJ: Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res 65: 8984-8992, 2005.
13. Scotlandi K, Benini S, Manara MC, Serra M, Nanni P, Lollini PL, Nicoletti G, Landuzzi L, Chano T, Picci P and Baldini N: Murine model for skeletal metastases of Ewing's sarcoma. J Orthop Res 18: 959-966, 2000.
14. Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA and Ilaria RL Jr: Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. Cancer Res 65: 8698-8705, 2005.
15. Armulik A, Abramsson A and Betsholtz C: Endothelial/pericyte interactions. Circ Res 97: 512-523, 2005.
16. Hellstrom M, Gerhardt H, Kaien M, Li X, Eriksson U, Wolburg H and Betsholtz C: Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153:543-553,2001.
17. Xu L, Tong R, Cochran DM and Jain RK: Blocking platelet-derived growth factor-D/pIatelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model. Cancer Res 65: 5711-5719,2005.
18. Bond M, Bernstein ML, Pappo A, Schultz KR, Krailo M, Blaney SM and Adamson PC: A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer 50: 254-258,2008.
19. Martins AS, Mackintosh C, Martin DH, Campos M, Hernandez T, Ordonez JL and de Alava E: Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor. Clin Cancer Res 12: 3532-3540,2006.